Yield10 Bioscience obtains positive response from USDA-APHIS on regulatory status of CRISPR genome-edited C3007 trait in camelina, paving way for US Field Tests
| | | |

Yield10 Bioscience obtains positive response from USDA-APHIS on regulatory status of CRISPR genome-edited C3007 trait in camelina, paving way for US Field Tests

On Apr. 27, 2020, Yield10 Bioscience announced it has obtained a positive response from USDA-APHISï¾’s Biotechnology Regulatory Services…

Vanda Pharma announces initiation of “CALYPSO” to study role of genetic variation in COVID-19 infections in collaboration with University of Washington Medicine
| | | | |

Vanda Pharma announces initiation of “CALYPSO” to study role of genetic variation in COVID-19 infections in collaboration with University of Washington Medicine

On Apr. 15, 2020, Vanda Pharma announced initiation of the CALYPSO program to study the role that human…